|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||215.293 g/mol g·mol−1|
|3D model (JSmol)|
|(what is this?)|
BRL-44408 is a drug used in scientific research which acts as a selective antagonist for the α2A adrenoreceptor. It has been suggested as having potential therapeutic application in the treatment of extrapyramidal side effects produced by some antipsychotic medications.
- Alberts P (January 1993). "Subtype classification of presynaptic alpha 2-adrenoceptors". General Pharmacology. 24 (1): 1–8. doi:10.1016/0306-3623(93)90003-g. PMID 8387042.
- Imaki J, Mae Y, Shimizu S, Ohno Y (April 2009). "Therapeutic potential of alpha2 adrenoceptor antagonism for antipsychotic-induced extrapyramidal motor disorders". Neuroscience Letters. 454 (2): 143–7. doi:10.1016/j.neulet.2009.03.001. PMID 19429072.
- Media related to BRL-44408 at Wikimedia Commons
|This antihypertensive-related article is a stub. You can help Wikipedia by expanding it.|